Shorter course of androgen deprivation therapy for high-risk prostate cancer patients yields improved quality of life — ScienceDaily
Researchers analyzed data from 561 patients with high-risk prostate cancer from a multi-center, randomized phase III trial in Canada (PCS IV clinical trials, Gov. # NCT 00223171). …